N,N′-dinitrosopiperazine-mediated AGR2 is involved in metastasis of nasopharyngeal carcinoma

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Li, Yuejin ^a   Lu, Jinping ^a   Peng, Zhengke ^a   Tan, Gongjun ^a   Liu, Na ^b   Huang, Damao ^b   Zhang, Zhenlin ^a   Duan, Chaojun ^b   Tang, Xiaowei ^b   Tang, Faqing ^a  

^a ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTERIOR GRADIENT 2 PROTEIN; CATHEPSIN B; CATHEPSIN D; N,N9 DINITROSOPIPERAZINE; ONCOPROTEIN; PIPERAZINE DERIVATIVE; UNCLASSIFIED DRUG; AGR2 PROTEIN, HUMAN; N,N'-DINITROSOPIPERAZINE; NITROSAMINE; PROTEIN; PROTEIN BINDING; SMALL INTERFERING RNA;

AGR2 GENE; ARTICLE; CANCER CELL LINE; CANCER GROWTH; CELL MOTILITY; CERVICAL LYMPH NODE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LYMPH NODE METASTASIS; METASTASIS; METASTASIS POTENTIAL; NASOPHARYNX CARCINOMA; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; TUMOR INVASION; CELL MOTION; ENZYMOLOGY; EPITHELIUM; IMMUNOHISTOCHEMISTRY; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE;

CATHEPSIN B; CATHEPSIN D; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIUM; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NITROSAMINES; PROTEIN BINDING; PROTEINS; RNA, SMALL INTERFERING;

EID: 84899515909     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092081     Document Type: Article

References (67)

1. Wei WI, Sham JST (2005) Nasopharyngeal carcinoma. The Lancet 365: 2041-2054. (Pubitemid 40812341)
2. Cao SM, Simons MJ, Qian CN (2011) The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 30: 114-119.
3. Chan AT (2010) Nasopharyngeal carcinoma. Annals of Oncology 21(Suppl): vii308-312.
4. Chua DT, Sham JS, Kwong DL, Wei WI, Au GK, et al. (1998) Locally recurrent nasopharyngeal carcinoma: treatment results for patients with computed tomography assessment. Int J Radiat Oncol Biol Phys 41: 379-386. (Pubitemid 28243550)
5. Al-Sarraf M, LeBlanc M, Giri PG,Fu KK, Cooper J, et al. (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. Journal of Clinical Oncology 16: 1310-1317. (Pubitemid 28175745)
6. Liebowitz D (1994) Nasopharyngeal carcinoma: the Epstein-Barr virus association. Semin Oncol 21: 376-381.
7. Simons MJ Nasopharyngeal carcinoma as a paradigm of cancer genetics. (2011) Chin J Cancer 30: 79-84.
8. Yu MC (1990) Diet and nasopharyngeal carcinoma. FEMS Microbiol Immunol 2: 235-242.
9. Henderson BE, Louie E. (1978) Discussion of risk factors for nasopharyngeal carcinoma. IARC Sci Publ 251-260.
10. Yu MC, Ho JH, Lai SH, Henderson BE (1986) Cantonese-style salted fish as a cause of nasopharyngeal carcinoma: report of a case-control study in Hong Kong. Cancer Res 46: 956-961. (Pubitemid 16145462)
11. Yu MC, Huang TB, Henderson BE (1989) Diet and nasopharyngeal carcinoma: a case-control study in Guangzhou, China. Int J Cancer 43: 1077-1082. (Pubitemid 19158041)
12. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, et al. (1998) Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer 77: 228-235. (Pubitemid 28287975)
13. Yuan JM, Wang XL, Xiang YB, Gao YT, Ross RK, et al. (2000) Preserved foods in relation to risk of nasopharyngeal carcinoma in Shanghai, China. Int J Cancer 85: 358-363. (Pubitemid 30030409)
14. Zou J, Sun Q, Akiba S, Yuan Y, Zha Y, et al. (2000) A case-control study of nasopharyngeal carcinoma in the high background radiation areas of Yangjiang, China. J Radiat Res (Tokyo) 41(Suppl): 53-62.
15. Jia WH, Luo XY, Feng BJ, Ruan HL, Bei JX, et al. (2010) Traditional Cantonese diet and nasopharyngeal carcinoma risk: a large-scale case-control study in Guangdong, China. BMC Cancer 10: 446.
16. Zou XN, Lu SH, Liu B (1994) Volatile N-nitrosamines and their precursors in Chinese salted fish-a possible etological factor for NPC in china. Int J Cancer 59: 155-158. (Pubitemid 24343354)
17. Poirier S, Hubert A, de-Thé G, Ohshima H, Bourgade MC, et al. (1987) Occurrence of volatile nitrosamines in food samples collected in three high-risk areas for nasopharyngeal carcinoma. IARC Sci Publ 415-419.
18. Lijinsky W, Kovatch RM (1993) Carcinogenic effects in rats of nitrosopiperazines administered intravesically: possible implications for the use of piperazine. Cancer Lett 74: 101-103. (Pubitemid 23331053)
19. Jakszyn P, Gonzalez CA (2006) Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol 12: 4296-4303. (Pubitemid 44194520)
20. Gallicchio L, Matanoski G, Tao XG, Chen L, Lam TK, et al. (2006) Adulthood consumption of preserved and nonpreserved vegetables and the risk of nasopharyngeal carcinoma: a systematic review. Int J Cancer 119: 1125-1135. (Pubitemid 44116922)
21. Huang DP, Ho JH, Saw D, Teoh TB (1978) Carcinoma of the nasal and paranasal regions in rats fed Cantonese salted marine fish. IARC Sci Publ 315-328.
22. Yu MC, Nichols PW, Zou XN, Estes J, Henderson BE (1989) Induction of malignant nasal cavity tumours in Wistar rats fed Chinese salted fish. Br J Cancer 60: 198-201. (Pubitemid 19207836)
23. Zheng X, Luo Y, Christensson B, Drettner B (1994) Induction of nasal and nasopharyngeal tumours in Sprague-Dawley rats fed with Chinese salted fish. Acta Otolaryngol 114: 98-104. (Pubitemid 24009243)
24. Tang F, Jiang H, Duan Z, Chen B, Jing Z, et al. (2001) [Profile of telomerase and telomerase RNA expression in nasopharyngeal carcinogenesis of rats induced by N, N′dinitrosopiperazine (DNP)]. Zhonghua Bing Li Xue Za Zhi 30: 125-128.
25. Tang FQ, Duan CJ, Huang DM, Wang WW, Xie CL, et al. (2009) HSP70 and mucin 5B: novel protein targets o f N, N′-dinitrosopiperazine -induced nasopharyngeal tumorigenesis. Cancer Sci 100: 216-224.
26. Tang F, Zou F, Peng Z, Huang D, Wu Y, et al. (2011) N,N′- Dinitrosopiperazine-mediated Ezrin Protein Phosphorylation via Activation of Rho Kinase and Protein Kinase C Is Involved in Metastasis of Nasopharyngeal Carcinoma 6-10B Cells. J Biol Chem 286: 36956-36967.
27. Li Y, Liu N, Huang D, Zhang Z, Peng Z, et al. (2012) Proteomic analysis on N, N′-dinitrosopiperazine-mediated metastasis of nasopharyngeal carcinoma 6-10B cells. BMC Biochem 13: 25.
28. Salmans ML, Zhao F, Andersen B (2012) The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker. Breast Cancer Res 15: 204.
29. Pizzi M, Fassan M, Balistreri M, Galligioni A, Rea F, et al. (2012) Anterior gradient 2 overexpression in lung adenocarcinoma. Appl Immunohistochem Mol Morphol 20: 31-36.
30. Chung K, Nishiyama N, Wanibuchi H, Yamano S, Hanada S, et al. (2012) AGR2 as a potential biomarker of human lung adenocarcinoma. Osaka City Med J 58: 13-24.
31. Park K, Chung YJ, So H, Kim K, Park J, et al. (2011) AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration. Exp Mol Med 43: 91-100.
32. Bu H, Bormann S, Schäfer G, Horninger W, Massoner P, et al. (2011) The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection. Prostate 71: 575-587.
33. Barraclough DL, Platt-Higgins A, de Silva Rudland S, Barraclough R, Winstanley J, et al. (2009) The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients. Am J Pathol 175: 1848-1857.
34. Vanderlaag KE, Hudak S, Bald L, Fayadat-Dilman L, Sathe M, et al. (2010) Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin. Breast Cancer Res 12: R32.
35. Dumartin L, Whiteman HJ, Weeks ME, Hariharan D, Dmitrovic B, et al. (2011) AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D. Cancer Res 71: 7091-7102.
36. Rao Malla R, Gopinath S, Alapati K, Gorantla B, Gondi CS, et al. (2013) Knockdown of cathepsin B and uPAR inhibits CD151 and alpha3beta1 integrin-mediated cell adhesion and invasion in glioma. Mol Carcinog 52: 777-790.
37. Li C, Chen L, Wang J, Zhang L, Tang P, et al. (2011) Expression and clinical significance of cathepsin B and stefin A in laryngeal cancer. Oncol Rep 26: 869-875.
38. Wu D, Wang H, Li Z, Wang L, Zheng F, et al. (2012) Cathepsin B may be a potential biomarker in cervical cancer. Histol Histopathol 27: 79-87.
39. Wu D, Li ZN, Xu Y, Wang LH, Ding L, et al. (2010) [Clinical significance of cathepsin B expressions in cervical cancer in tissues]. Nan Fang Yi Ke Da Xue Xue Bao 30: 1330-1332.
40. Lodillinsky C, Rodriguez V, Vauthay L, Sandes E, Casabé A, et al. (2009) Novel invasive orthotopic bladder cancer model with high cathepsin B activity resembling human bladder cancer. J Urol 182: 749-755.
41. Herszényi L, István G, Cardin R, De Paoli M, Plebani M, et al. (2008) Serum cathepsin B and plasma urokinase-type plasminogen activator levels in gastrointestinal tract cancers. Eur J Cancer Prev 17: 438-445.
42. Czyzewska J, Guzińska-Ustymowicz K, Kemona A, Bandurski R (2008) The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival. Folia Histochem Cytobiol 46: 57-64.
43. Yu B, Li SY, An P, Zuo FY, Cai HY (2004) [Expression of cathepsin B and its clinical importance in colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 8: 507-509.
44. Wickramasinghe NS, Nagaraj NS, Vigneswaran N, Zacharias W (2005) Cathepsin B promotes both motility and invasiveness of oral carcinoma cells. Arch Biochem Biophys 436: 187-195. (Pubitemid 40332438)
45. Sevenich L, Werner F, Gajda M, Schurigt U, Sieber C, et al. (2011) Transgenic expression of human cathepsin B promotes progression and metastasis of polyoma-middle-T-induced breast cancer in mice. Oncogene 30: 54-64.
46. Withana NP, Blum G, Sameni M, Slaney C, Anbalagan A, et al. (2012) Cathepsin B inhibition limits bone metastasis in breast cancer. Cancer Res 72: 1199-1209.
47. Nouh MA, Mohamed MM, El-Shinawi M, Shaalan MA, Cavallo-Medved D, et al. (2011) Cathepsin B: a potential prognostic marker for inflammatory breast cancer. J Transl Med 9: 1.
48. Paksoy M, Hardal U, Caglar C (2011) Expression of cathepsin D and E-cadherin in primary laryngeal cancers correlation with neck lymph node involvement. J Cancer Res Clin Oncol 137: 1371-1377.
49. del Casar JM, Corte MD, Alvarez A, García I, Bongera M, et al. (2008) Lymphatic and/or blood vessel invasion in gastric cancer: relationship with clinicopathological parameters, biological factors and prognostic significance. J Cancer Res Clin Oncol 134: 153-161. (Pubitemid 350234059)
50. Abbott DE, Margaryan NV, Jeruss JS, Khan S, Kaklamani V, et al. (2010) Reevaluating cathepsin D as a biomarker for breast cancer: serum activity levels versus histopathology. Cancer Biol Ther 9: 23-30.
51. Ohri SS, Vashishta A, Proctor M, Fusek M, Vetvicka V (2008) The propeptide of cathepsin D increases proliferation, invasion and metastasis of breast cancer cells. Int J Oncol 32: 491-498. (Pubitemid 351188316)
52. Szajda SD, Snarska J, Jankowska A, Roszkowska-Jakimiec W, Puchalski Z, et al. (2008) Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients. Hepatogastroenterology 55: 388-393. (Pubitemid 351741467)
53. Kaneko I, Tanaka S, Oka S, Yoshida S, Hiyama T, et al. (2007) Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer. World J Gastroenterol 13: 3829-3835. (Pubitemid 47272308)
54. Gan Y, Zhao X, Hu J, Wang ZG, Zhao XT (2008) HCCS1 overexpression induces apoptosis via cathepsin D and intracellular calcium, and HCCS1 disruption in mice causes placental abnormality. Cell Death Differ 15: 1481-1890.
55. Szajda SD, Snarska J, Roszkowska-Jakimiec W, Waszkiewicz N, Siedlecka K, et al. (2006) [Activity of cathepsin D in the blood serum and urine of patients with cancer of the stomach, pancreas and liver]. Pol Arch Med Wewn 116: 1150-1154.
56. Cheng AL, Huang WG, Chen ZC, Zhang PF, Li MY, et al. (2008) Identificating cathepsin D as a biomarker for differentiation and prognosis of nasopharyngeal carcinoma by laser capture microdissection and proteomic analysis. J Proteome Res 7: 2415-2426.
57. Peng Z, Liu N, Huang D, Duan C, Li Y, et al. (2013) N,N′- dinitrosopiperazine-mediated heat-shock protein 70-2 expression is involved in metastasis of nasopharyngeal carcinoma. Plos One 8: e62908.
58. Chew MM, Gan SY, Khoo AS, Tan EL (2010) Interleukins, laminin and Epstein - Barr virus latent membrane protein 1 (EBV LMP1) promote metastatic phenotype in nasopharyngeal carcinoma. BMC Cancer 10: 574.
59. Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, et al. (2010) Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog 6: e1000940.
60. Bartsch H, Ohshima H, Pignatelli B, Calmels S (1992) Endogenously formed N-nitroso compounds and nitrosating agents in human cancer etiology. Pharmacogenetics 2: 272-277.
61. Preston-Martin S, Correa P. (1989) Epidemiological evidence for the role of nitroso compounds in human cancer. Cancer Surv 8: 459-973.
62. Chen ZC, Pan SC, Yao KT (1991) Chemical transformation of human embryonic nasopharyngeal epithelial cells in vitro. IARC Sci Publ 1991; 434-438.
63. Brychtova V, Vojtesek B, Hrstka R (2011) Anterior gradient 2: a novel player in tumor cell biology. Cancer Lett 304: 1-7.
64. Ramachandran V, Arumugam T, Wang H, Logsdon CD (2008) Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival. Cancer Res 68: 7811-7818.
65. Zweitzig DR, Smirnov DA, Connelly MC, Terstappen LW, O'Hara SM, et al. (2007) Physiological stress induces the metastasis marker AGR2 in breast cancer cells. Mol Cell Biochem 306: 255-260. (Pubitemid 350001838)
66. Lively S, Schlichter LC (2013) The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. J Neuroinflammation 10: 75.
67. Wang X, Li L, Hu C, Zhou Z, Ying H, et al. (2008) Patterns of level II node metastasis in nasopharyngeal carcinoma. Radiother Oncol 89: 28-32.